Champions Oncology (CSBR)
(Delayed Data from NSDQ)
$4.77 USD
-0.12 (-2.45%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $4.82 +0.05 (1.05%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Champions Oncology, Inc. [CSBR]
Reports for Purchase
Showing records 1 - 20 ( 38 total )
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
We are updating our Healthcare coverage to reflect a recent analyst departure and to drop
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for CSBR 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Company: Champions Oncology, Inc.
Industry: Medical - Drugs
Reasons to Sit Down with These Healthcare/Biotech Management
Provider: Roth Capital Partners, Inc.
Analyst: PIROS E